Agronomics investee Meatable agrees to buy cultivated meat platform

Agronomics Ltd on Friday said portfolio company Meatable BV has agreed to acquire Uncommon Bio Ltd’s cultivated meat platform.

Agronomics is an Isle of Man-based investor in cellular agriculture, and Meatable is a Delft, Netherlands-based biotechnology company focused on cultured meat. Uncommon Bio is a Cambridge, England-based biotechnology research firm.

To date, Agronomics has invested a total of £7.9 million in Meatable, which is currently carried at £11.7 million and represents around 8.1% of Agronomics’s net asset value at June 30.

Meatable said the integration of Uncommon Bio’s non-genetically modified organism mRNA reprogramming and saRNA differentiation technologies means Meatable now operates the only ‘true’ multi-platform cultivated meat technology offering.

Meatable will pair its patented opti-ox system with Uncommon Bio technology.

‘With this acquisition, Meatable is reinforcing its position as a global leader in cultivated meat, proving what is possible when the world’s sharpest minds address one of our greatest challenges: feeding a growing planet amid rising meat demand and shrinking supply,’ said Agronomics Executive Chair Jim Mellon.

‘By combining Uncommon’s platform with its own, Meatable will have an enviable offering for prospective customers, offering greater choice and scalability, and answering the global call for a protein supply chain which can help moderate price volatility, and boost food security.’

Shares in Agronomics were down 0.7% at 7.45 pence in London on Friday morning. The stock has risen 26% over the past year.

Copyright 2025 Alliance News Ltd. All Rights Reserved.